The “Iron Prohibition Law” has been around for almost four decades. In simple terms, it posits that as law enforcement intensifies, the potency of banned substances tends to increase. This idea often comes up in discussions about shifts in the drug trade, particularly during the ongoing opioid crisis in the U.S. While it sounds reasonable, the theory is quite flawed and overlooks a significant factor: economics.
I’ve started questioning this concept. Keith Humphreys, a professor from Stanford, pointed out that the Iron Prohibition might be getting outdated. Yet, despite this observation, prohibition is often still blamed for worsening issues like the increasing dangers and complexities of drug supplies.
Ultimately, this is about business.
Drug traffickers operate like any profit-seeking enterprise. Their decision-making primarily revolves around reducing risk while maximizing profits. With synthetic drugs often being more advantageous than traditional plant-based drugs, it’s predictable that traffickers would lean towards them. Honestly, I’m surprised it took this long for them to make the switch.
For years, traffickers in Latin America have focused on crops like coca, poppy, and cannabis because they have the right conditions for growth and not many other economic prospects. Yet, farming is time-consuming, labor-intensive, and vulnerable to challenges like drought or disease, making it less profitable.
On the ground, peasant farmers earn very little, just enough to scrape by. While this method of drug production has persisted, advancements in technology and globalization have drastically altered the illegal drug market.
Today, synthetic drugs are on the rise—not because of prohibition, but because they are cheaper and more lucrative than their plant-based analogs.
Imagine running a business where avocados sell for $1,000 per kilogram. Then you stumble upon a lab-made version that can sell for $50,000 per kilogram. That’s how we find ourselves with drugs like fentanyl.
So, what does this mean for the Iron Prohibition? Whether one views the emergence of synthetic drugs as a reaction to prohibition or a strategic shift among dealers, these substances are here to stay.
It’s clear that merely making arrests won’t solve the drug crisis. Effective drug control needs a well-rounded strategy that includes reducing demand, harm reduction, and investments in treatment. Still, enforcement plays a crucial role, and if executed properly, it can lead to significant results.
Back in the late ’90s and early 2000s, coordinated enforcement efforts in the U.S. and Colombia dismantled two major drug cartels, the Medellin and Cali. When the U.S. introduced the Fighting the Methamphetamine Epidemic Prevention Act in 2005, aiming to tightly regulate sales of ephedrine and pseudoephedrine, the landscape changed. Most recently, after China banned fentanyl-related substances in 2019, shipments of fentanyl to the U.S. dwindled significantly.
Yes, Colombia’s cocaine business continues, and as regulations ramp up in the U.S. and China, drug production has shifted to Mexico—a typical case of the “balloon effect.” The rise of synthetic drugs, which can be made anywhere, underscores the necessity for effective drug management globally. The persistence of drug trafficking in places like Colombia and Mexico primarily points to authorities’ inability to effectively intervene.
So, what’s the solution? It isn’t to drop enforcement entirely. Rather, there’s a pressing need for the international community to bolster security cooperation, strengthen institutions, and enhance enforcement efforts where they matter most. We have to work collectively to address the underlying issues.
It’s true that crackdowns alone won’t resolve the drug crisis. The real challenge lies in addressing the constant demand for illicit drugs from the American public. As a character in *Sicario* once noted, “Order is the best we can hope for.”
The landscape of illegal drugs is constantly changing, with new, deadly substances emerging consistently. Meanwhile, traffickers adapt their strategies in relentless pursuit of profit.
This new era of synthetic drugs calls for fresh thinking and a proactive approach. We should reflect on how we reached this point and seek solutions, rather than placing blame on prohibition.
